These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20184146)

  • 21. Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.
    Mandel S; Amit T; Bar-Am O; Youdim MB
    Prog Neurobiol; 2007 Aug; 82(6):348-60. PubMed ID: 17659826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Viewpoint on the methodology of drug trials affecting cognition of elderly patients].
    Allain H; Bernard PM; Dartigues JF; Dérouesné C; Dubois B; Hugonot L; Laurent B; Léger JM; Malauzat D; Michel B
    Encephale; 1994; 20(6):725-39. PubMed ID: 7875107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?
    Isingrini E; Desmidt T; Belzung C; Camus V
    Curr Opin Investig Drugs; 2009 Jan; 10(1):46-55. PubMed ID: 19127486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of chronic brain hypoperfusion in the pathogenesis of Alzheimer's disease--facts and hypotheses].
    Zádori D; Datki Z; Penke B
    Ideggyogy Sz; 2007 Nov; 60(11-12):428-37. PubMed ID: 18198789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic models of Alzheimer's disease.
    Patel S; Tariot PN
    Psychiatr Clin North Am; 1991 Jun; 14(2):287-308. PubMed ID: 2062722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging Alzheimer's amyloid.
    Selkoe DJ
    Nat Biotechnol; 2000 Aug; 18(8):823-4. PubMed ID: 10932146
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clearing amyloid through the blood-brain barrier.
    Zlokovic BV
    J Neurochem; 2004 May; 89(4):807-11. PubMed ID: 15140180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI
    Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New drugs for Alzheimer's disease.
    Delagarza VW
    Am Fam Physician; 1998 Oct; 58(5):1175-82. PubMed ID: 9787282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unraveling Alzheimer's. Scientists are close to figuring out how the disorder destroys brains. But will their knowledge save lives?
    Gorman C
    Time; 2000 Jul; 156(2):98-9. PubMed ID: 10977415
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroendocrinology-based therapy for Alzheimer's disease.
    Palm R; Ayala-Fontanez N; Garcia Y; Lee HG; Smith MA; Casadesus G
    Biofactors; 2012; 38(2):123-32. PubMed ID: 22438197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facing the complexity of Alzheimer's disease.
    Dallemagne P; Rochais C
    Future Med Chem; 2020 Feb; 12(3):175-177. PubMed ID: 31747794
    [No Abstract]   [Full Text] [Related]  

  • 35. Alzheimer's disease: recent advances and future prospects.
    Deakin JF
    Br Med J (Clin Res Ed); 1983 Nov; 287(6402):1323-4. PubMed ID: 6416395
    [No Abstract]   [Full Text] [Related]  

  • 36. Can we reverse Alzheimer's? New approaches from Harvard offer hope.
    Harv Health Lett; 2013 Jan; 38(3):1, 7. PubMed ID: 23556155
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanically interlocked molecular architectures functionalised with fullerenes.
    Mateo-Alonso A
    Chem Commun (Camb); 2010 Dec; 46(48):9089-99. PubMed ID: 21085726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Origins of fullerenes in rocks.
    Ebbesen TW; Hiura H; Hedenquist JW; de Ronde CE; Andersen A; Often M; Melezhik VA
    Science; 1995 Jun; 268(5217):1634-5. PubMed ID: 17754616
    [No Abstract]   [Full Text] [Related]  

  • 39. Fullerenes on the half shell.
    Science; 1995 Jul; 269(5222):305-7. PubMed ID: 17841234
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinct Impacts of Fullerene on Cognitive Functions of Dementia vs. Non-dementia Mice.
    Wu Y; Wang R; Wang Y; Gao J; Feng L; Yang Z
    Neurotox Res; 2019 Nov; 36(4):736-745. PubMed ID: 31222673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.